- Galaxies of Hope offers a unique digital experience
that engages users through the art of visual storytelling to
connect with others to understand NET cancer
- Using real-life stories and voices of patients, caregivers,
and physicians in the NET community, the app aims to immerse users
in their personal journeys
- The app, developed in collaboration with Numinous Games,
award-winning video game developers, is now available on the App
Store
EAST HANOVER, N.J.,
July 12, 2018 /PRNewswire/
-- Novartis today launched its Galaxies of Hope app, a unique
digital experience created to support the neuroendocrine tumor
(NET) community. Galaxies of Hope engages users through the art of
visual storytelling, using the actual words and voices of patients,
caregivers, and physicians who are part of the NET cancer
community. This digital experience is divided into three different
"journey" types, one for each of these groups. Users can explore
the different galaxies within the journeys to connect with the
experiences of patients, caregivers, and physicians involved in the
NET patient journey. Galaxies of Hope is now available to download
for free on the App Store for iPhone and iPad in the US only.
Novartis believes that raising awareness of NET cancer in
creative ways is important in improving understanding and
management of this rare disease. Novartis collaborated with
Numinous Games, award-winning video game developers, to create
Galaxies of Hope. It is a content-rich, poetic, and interactive
digital experience which presents a new and unique way for NET
cancer patients, caregivers, and physicians to learn more about the
emotional course of this disease.
"At Novartis, our vision is to reimagine how we can provide new
platforms for patient support. We believe that this app can have a
real, positive impact in the NET cancer community," said
Ameet Mallik, Executive Vice
President and Head, US Oncology at Novartis. "We hope that the
creation of this virtual patient journey experience for the NET
cancer community will provide support to those living with this
rare disease and those who manage and care for them."
Galaxies of Hope will be available in the Google Play Store
in the US only in the coming weeks.
About Neuroendocrine Tumors
Neuroendocrine tumors
(NET) develop from cells that produce and secrete a variety of
hormones that regulate bodily functions. There are many types of
NET cancers that can occur throughout the body; however, most are
found in the gastrointestinal tract, pancreas and lungs. For
example, carcinoid tumors are a type of NET that frequently
originate in the gastrointestinal tract or lungs. Another type is
pancreatic NET, sometimes called islet cell tumors.
About Novartis
Located in East Hanover, NJ Novartis Pharmaceuticals
Corporation is an affiliate of Novartis which provides innovative
healthcare solutions that address the evolving needs of patients
and societies. Headquartered in Basel,
Switzerland, Novartis offers a diversified portfolio to best
meet these needs: innovative medicines, cost-saving generic and
biosimilar pharmaceuticals and eye care. Novartis has leading
positions globally in each of these areas. In 2017, the Group
achieved net sales of USD 49.1
billion, while R&D throughout the Group amounted to
approximately USD 9.0 billion.
Novartis Group companies employ approximately 124,000
full-time-equivalent associates. Novartis products are sold in
approximately 155 countries around the world. For more information,
please visit http://www.novartis.com.
Novartis is on Twitter. Sign up to follow @Novartis at
http://twitter.com/novartis
For Novartis multimedia content, please visit
www.novartis.com/news/media-library
For questions about the site or required registration, please
contact media.relations@novartis.com
Novartis Media Relations
Central media line: +41 61
324 2200
E-mail: media.relations@novartis.com
Eric
Althoff
Novartis Global Media
Relations
+1 212-830-2408
(office)
+1 646 438 4335
(mobile)
+41 79 593 4202
(mobile)
eric.althoff@novartis.com
|
Rosemarie
Yancosek
Novartis Oncology
Communications
+1 862 778 9043
(office)
+1 862 505 9021
(mobile)
rosemarie.yancosek@novartis.com
|
Novartis Investor Relations
E-mail:
investor.relations@novartis.com
North
America
|
|
Richard
Pulik
|
+1 212 830
2448
|
Cory
Twining
|
+1 212 830
2417
|
|
|
|
|
View original
content:http://www.prnewswire.com/news-releases/novartis-launches-the-galaxies-of-hope-app-a-digital-experience-for-the-neuroendocrine-tumor-net-cancer-community-300679819.html
SOURCE Novartis Pharmaceuticals Corporation